scispace - formally typeset
S

Stuart M. Brierley

Researcher at Flinders University

Publications -  138
Citations -  6667

Stuart M. Brierley is an academic researcher from Flinders University. The author has contributed to research in topics: Visceral pain & Irritable bowel syndrome. The author has an hindex of 41, co-authored 126 publications receiving 5482 citations. Previous affiliations of Stuart M. Brierley include University of South Australia & Royal Adelaide Hospital.

Papers
More filters
Journal ArticleDOI

Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways

TL;DR: C cultured intestinal organoids are exploited together with single-cell measurements to elucidate intrinsic biophysical, pharmacological, and genetic properties of EC cells, showing that EC cells express specific chemosensory receptors, are electrically excitable, and modulate serotonin-sensitive primary afferent nerve fibers via synaptic connections, enabling them to detect and transduce environmental, metabolic, and homeostatic information from the gut directly to the nervous system.
Journal ArticleDOI

Splanchnic and pelvic mechanosensory afferents signal different qualities of colonic stimuli in mice

TL;DR: The splanchnic and pelvic pathways contain distinct populations of mechanosensitive afferents, which are capable of detecting an array of mechanical stimuli and are individually tuned to detect the type, magnitude, and duration of the stimulus.
Journal ArticleDOI

Different contributions of ASIC channels 1a, 2, and 3 in gastrointestinal mechanosensory function

TL;DR: These data show that ASIC3 makes a critical positive contribution to mechanosensitivity in three out of four classes of visceral afferents, suggesting that targeting these subunits with pharmacological agents may have different and more pronounced effects on mechanos sensitivity in the viscera.
Journal ArticleDOI

Selective Role for TRPV4 Ion Channels in Visceral Sensory Pathways

TL;DR: It is proposed that TRPV4 may present a selective novel target for the reduction of visceral pain, which is an important opportunity in the absence of current treatments.